Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study Between High and Low Dose Methylene Blue Infusion in Septic Cancer Patients. A Randomized Blinded Controlled Study

NCT06005558 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT06005558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study Between High and Low Dose Methylene Blue Infusion in Septic Cancer Patients. A Randomized Blinded Controlled Study
Lead sponsor
National Cancer Institute, Egypt
Phase
Phase 2/3
Overall status
Completed
Start date
August 1, 2023
Completion date
May 15, 2024
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock